𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma

✍ Scribed by Rodríguez-Perálvarez, Manuel; Tsochatzis, Emmanuel; Naveas, María Carmen; Pieri, Giulia; García-Caparrós, Carmen; O’Beirne, James; Poyato-González, Antonio; Ferrín-Sánchez, Gustavo; Montero-Álvarez, Jose Luis; Patch, David; Thorburn, Douglas; Briceño, Javier; De la Mata, Manuel; Burroughs, Andrew Kenneth

Book ID
123229815
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
691 KB
Volume
59
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Late Recurrence of Hepatocellular Carcin
Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation
✍ Kenneth S. H. Chok; See Ching Chan; Tan To Cheung; Albert C. Y. Chan; Sheung Tat 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 246 KB

## Background Long-term survival of patients with hepatocellular carcinoma (HCC) after liver transplantation is affected mainly by recurrence of HCC. There is the opinion that the chance of recurrence after 2 years post-transplantation is remote, and therefore lifelong surveillance is not justified

Recurrent hepatocellular carcinoma after
Recurrent hepatocellular carcinoma after transplantation: Use of a pathological score on explanted livers to predict recurrence
✍ Jeremy R. Parfitt; Paul Marotta; Mohammed AlGhamdi; William Wall; Anand Khakhar; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB

Francisco (UCSF) criteria are used to select patients with hepatocellular carcinoma (HCC) for liver transplantation (LT). Recurrent HCC is a significant cause of death. There is no widely accepted pathological assessment strategy to predict recurrent HCC after transplantation. This study compares th